You are currently on the new version of our website. Access the old version .
Clinics and PracticeClinics and Practice
  • Clinics and Practice is published by MDPI from Volume 11 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
  • Case Report
  • Open Access

7 May 2019

Non-Traumatic Splenic Rupture in Amyloidosis as a Rare Evolution of Multiple Myeloma

,
,
,
and
1
Department of Oncology, Maugeri Clinical and Scientific Institutes (IRCCS), Pavia, Italy
2
Department of Internal Medicine, University of Pavia, Pavia, Italy
3
PhD Program in Experimental Medicine, University of Pavia, Pavia, Italy
*
Author to whom correspondence should be addressed.

Abstract

We report the case of a 64-year-old man with a diagnosis of IgG lambda multiple myeloma (MM) symptomatic for bone lesions for which he received autologous stem cell transplant after induction treatment and high-dose melphalan, thalidomide and lenalidomide therapy. Twelve years after the diagnosis, he had an unexpected and acute onset of abdominal pain with signs of hypovolemic shock. A computed tomography scan was immediately performed and demonstrated a splenic rupture. A splenectomy was performed but, a week after, the patient developed an acute respiratory distress syndrome and died. After histological exam of the spleen, non-traumatic spleen rupture due to amyloidosis was our final diagnosis. This event is potentially fatal and rare in patients with MM; clinicians should be aware of this potential course of the disease and monitor patients also for amyloid induced organ damages.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.